Study Puts a $43 Billion Yearly Price Tag on Cancer Screening

The United States spent a significant amount annually on cancer screening, according to a comprehensive estimate. Cancer screening accounts for a substantial proportion of the total expenditure on cancer in the country. The estimate focuses on breast, cervical, colorectal, lung, and prostate cancers. Private insurance covers more than 88% of screening costs, with government programs covering the rest. The high cost is surprising and is likely an underestimate. Screening is seen as valuable for early detection and improving chances of survival.